SUPPLEMENTAL FINANCIAL INFORMATION
STOCK-BASED COMPENSATION EXPENSE
(Unaudited, in thousands)
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Cost of revenue | $ | 885 | $ | 642 | $ | 1,700 | $ | 1,199 | ||||||||
| Research and development | 6,752 | 4,962 | 12,918 | 9,332 | ||||||||||||
| Selling, general and administrative | 24,489 | 15,440 | 46,092 | 29,075 | ||||||||||||
| Total stock-based compensation expense | $ | 32,126 | $ | 21,044 | $ | 60,710 | $ | 39,606 | ||||||||
RECONCILIATION OF NET INCOME TO NON-GAAP NET INCOME
(Unaudited, in thousands, except per share amounts)
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Net income | $ | 55,169 | $ | 30,167 | $ | 100,582 | $ | 65,922 | ||||||||
| Adjustments to reconcile net income to non-GAAP net income: | ||||||||||||||||
| Stock-based compensation expense | 32,126 | 21,044 | 60,710 | 39,606 | ||||||||||||
| Deferred compensation plan expense | 290 | 460 | 233 | 554 | ||||||||||||
| Tax effect | (1,117 | ) | (1,111 | ) | (5,578 | ) | (11,189 | ) | ||||||||
| Non-GAAP net income | $ | 86,468 | $ | 50,560 | $ | 155,947 | $ | 94,893 | ||||||||
| Non-GAAP net income per share: | ||||||||||||||||
| Basic | $ | 1.89 | $ | 1.13 | $ | 3.42 | $ | 2.13 | ||||||||
| Diluted | $ | 1.81 | $ | 1.08 | $ | 3.27 | $ | 2.03 | ||||||||
| Shares used in the calculation of non-GAAP net income per share: | ||||||||||||||||
| Basic | 45,796 | 44,785 | 45,647 | 44,620 | ||||||||||||
| Diluted | 47,754 | 46,831 | 47,732 | 46,750 | ||||||||||||
